Colgate-Palmolive (NYSE:CL – Get Free Report) had its price objective boosted by analysts at Jefferies Financial Group from $85.00 to $91.00 in a research note issued to investors on Monday,Benzinga reports. The brokerage currently has a “hold” rating on the stock. Jefferies Financial Group’s target price suggests a potential downside of 0.82% from the stock’s previous close.
Other equities analysts have also issued reports about the stock. JPMorgan Chase & Co. increased their price objective on shares of Colgate-Palmolive from $93.00 to $97.00 and gave the company an “overweight” rating in a research report on Monday. The Goldman Sachs Group reiterated a “buy” rating and issued a $94.00 price target on shares of Colgate-Palmolive in a research note on Saturday. Royal Bank Of Canada upgraded shares of Colgate-Palmolive from a “sector perform” rating to an “outperform” rating and set a $88.00 price objective for the company in a research report on Tuesday, December 9th. Wells Fargo & Company boosted their price objective on Colgate-Palmolive from $86.00 to $94.00 and gave the stock an “equal weight” rating in a report on Sunday. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of Colgate-Palmolive in a research note on Wednesday, January 21st. Eleven equities research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. Based on data from MarketBeat, Colgate-Palmolive currently has a consensus rating of “Moderate Buy” and a consensus target price of $94.06.
Read Our Latest Stock Report on CL
Colgate-Palmolive Stock Performance
Colgate-Palmolive (NYSE:CL – Get Free Report) last issued its earnings results on Friday, January 30th. The company reported $0.95 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.91 by $0.04. Colgate-Palmolive had a net margin of 10.45% and a return on equity of 353.72%. The business had revenue of $5.23 billion during the quarter, compared to the consensus estimate of $5.13 billion. During the same period last year, the business posted $0.91 EPS. Colgate-Palmolive’s revenue was up 5.8% on a year-over-year basis. As a group, sell-side analysts anticipate that Colgate-Palmolive will post 3.75 EPS for the current year.
Institutional Investors Weigh In On Colgate-Palmolive
A number of large investors have recently bought and sold shares of CL. Sunpointe LLC boosted its position in shares of Colgate-Palmolive by 4.0% during the 4th quarter. Sunpointe LLC now owns 3,056 shares of the company’s stock worth $241,000 after acquiring an additional 117 shares in the last quarter. Grimes & Company Inc. lifted its stake in Colgate-Palmolive by 1.0% during the second quarter. Grimes & Company Inc. now owns 12,495 shares of the company’s stock worth $1,136,000 after purchasing an additional 118 shares during the last quarter. RFG Advisory LLC boosted its holdings in shares of Colgate-Palmolive by 1.4% in the 2nd quarter. RFG Advisory LLC now owns 9,227 shares of the company’s stock valued at $839,000 after purchasing an additional 123 shares in the last quarter. Tiemann Investment Advisors LLC increased its stake in shares of Colgate-Palmolive by 2.1% in the 2nd quarter. Tiemann Investment Advisors LLC now owns 6,083 shares of the company’s stock valued at $553,000 after purchasing an additional 125 shares during the last quarter. Finally, Capital Advisors Inc. OK raised its holdings in shares of Colgate-Palmolive by 1.4% during the 4th quarter. Capital Advisors Inc. OK now owns 9,595 shares of the company’s stock worth $758,000 after buying an additional 129 shares in the last quarter. 80.41% of the stock is currently owned by institutional investors and hedge funds.
Colgate-Palmolive News Roundup
Here are the key news stories impacting Colgate-Palmolive this week:
- Positive Sentiment: Better?than?expected Q4: Colgate reported organic sales and earnings that beat estimates, giving analysts confidence in near?term momentum and supporting the stock’s gains. Colgate-Palmolive Q4 Organic Sales Rise 2.2%, Beating Estimates
- Positive Sentiment: Analysts lift forecasts broadly: Multiple firms raised price targets and ratings after the quarter, signaling renewed analyst conviction. Colgate-Palmolive Analysts Boost Their Forecasts Following Better-Than-Expected Q4 Results
- Positive Sentiment: Bank of America raised its price target to $100 and kept a Buy rating, indicating ~9% upside vs. recent levels. Bank of America price target note (Benzinga)
- Positive Sentiment: Evercore ISI raised its target to $100 with an Outperform rating, another bullish signal from the sell?side. Evercore ISI raises price target (TickerReport)
- Positive Sentiment: JPMorgan upgraded its target to $97 and set an Overweight rating, adding to the upward pressure. JPMorgan price target note (Benzinga)
- Positive Sentiment: Analyst reaffirmations: TD Cowen and Bank of America research notes continue to highlight premiumization, pet nutrition and emerging?market strength as medium?term growth drivers. Colgate-Palmolive: Strengthening Earnings Visibility (TipRanks)
- Neutral Sentiment: Market reaction coverage: News outlets note a sizable intraday move after the results and outlook commentary; useful for trade/flow context but not a fundamental change. Colgate-Palmolive (CL) Climbs 6% on Upbeat Outlook Despite Headwinds
- Neutral Sentiment: Talent strategy piece: Fortune profiles Colgate’s global rotations to develop leaders — a long?term organizational positive but unlikely to move near?term earnings. Why Colgate-Palmolive is moving talent across borders to develop leaders
- Negative Sentiment: Deutsche Bank remains cautious: It set a $90 target and a Hold rating, implying limited upside (slight downside vs. recent levels), which could cap how bullish some investors are. Deutsche Bank Hold / $90 target (TickerReport)
- Negative Sentiment: Consumer?uncertainty warning: Coverage notes that while sales rose, consumer spending softness could cloud the outlook, a risk to watch for margins and volume trends. Colgate Sales Rise, but Consumer Uncertainty Clouds Outlook (MSN)
About Colgate-Palmolive
Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.
The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.
See Also
- Five stocks we like better than Colgate-Palmolive
- Nvidia Chief: Billions Could Flow Here Next…
- Huge robotics rollout underway
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
- Bombshell Exposé on China Strikes
- Trump’s Final Shocking Act Begins February 24
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.
